Stoke Therapeutics STOK
NASDAQ STOK
$27.16 -0.05 (-0.18%)
As of: Nov 11, 2026 · 11:14 AM EST

Stoke Therapeutics (STOK) Non-Current Deferred Revenue (2022 - 2026)

Updated

Analysis

Stoke Therapeutics (STOK) Non-Current Deferred Revenue (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Stoke Therapeutics 1.76 Bn 523.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.45 Mn
Jun 30, 2026 5.65 Mn
Mar 31, 2026 6.60 Mn
Dec 31, 2025 6.96 Mn
Sep 30, 2025 8.56 Mn
Jun 30, 2025 9.63 Mn
Mar 31, 2025 10.26 Mn
Sep 30, 2024 8.29 Mn
Jun 30, 2024 16.95 Mn
Mar 31, 2024 25.04 Mn
Dec 31, 2023 33.07 Mn
Sep 30, 2023 40.73 Mn
Jun 30, 2023 43.26 Mn
Mar 31, 2023 34.14 Mn
Dec 31, 2022 36.86 Mn
Sep 30, 2022 41.08 Mn
Jun 30, 2022 45.21 Mn
Mar 31, 2022 49.55 Mn
API Access

Stoke Therapeutics Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=STOK&period=max&api_key=YOUR_API_KEY